Literature DB >> 15479490

Double primary cancers of the prostate and bladder: a literature review.

Yoshihisa Kinoshita1, Amar Singh, Peter M Rovito, Ching Y Wang, Gabriel P Haas.   

Abstract

A number of studies report a high frequency of double primary cancers of the bladder and prostate. The coincidence was as high as 70% for prostate cancers in patients with bladder cancer, and 3.4% for bladder cancers in patients with prostate cancer. Two studies reviewing medical records reported a significant risk of bladder cancer after prostate cancer and of prostate cancer after bladder cancer. Only 1 of 3 cancer registry studies reported a significantly increased risk of prostate cancer after bladder cancer, and 3 of 11 studies reported a significantly increased risk in bladder cancer after prostate cancer. There was an association between DNA repair and N-acetyltransferase polymorphisms and risk of prostate and bladder cancer. These data suggest that these cancers may share a common carcinogenic process or that these patients are particularly susceptible to both cancers. Because of the association between these cancers, patients who are diagnosed with prostate or bladder cancer should be followed closely for the detection of the second urologic malignancy.

Entities:  

Mesh:

Year:  2004        PMID: 15479490     DOI: 10.3816/cgc.2004.n.016

Source DB:  PubMed          Journal:  Clin Prostate Cancer        ISSN: 1540-0352


  12 in total

Review 1.  A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.

Authors:  Chunming Gong; Xueying Hu; Yong Gao; Yunfei Cao; Feng Gao; Zengnan Mo
Journal:  Med Oncol       Date:  2010-01-23       Impact factor: 3.064

2.  Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy.

Authors:  Shulin Wu; Sharron X Lin; Min Lu; Alexander O Subtelny; Zongwei Wang; Douglas M Dahl; Aria F Olumi; Chin-Lee Wu
Journal:  Int Urol Nephrol       Date:  2019-06-10       Impact factor: 2.370

3.  The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.

Authors:  Gabriel P Haas; Nicolas Delongchamps; Otis W Brawley; Ching Y Wang; Gustavo de la Roza
Journal:  Can J Urol       Date:  2008-02       Impact factor: 1.344

4.  A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.

Authors:  Hao Liu; Kari Hemminki; Jan Sundquist; Bernd Holleczek; Alexander Katalinic; Katharina Emrich; Lina Jansen; Hermann Brenner
Journal:  Cancer Med       Date:  2013-08-27       Impact factor: 4.452

5.  Prognosis of prostate cancer with other primary malignancies.

Authors:  Ju Hyun Lim; Dalsan You; In Gab Jeong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Korean J Urol       Date:  2014-05-12

6.  Androgen deprivation therapy prevents bladder cancer recurrence.

Authors:  Koji Izumi; Masataka Taguri; Hiroshi Miyamoto; Yoshinori Hara; Takeshi Kishida; Kimio Chiba; Tetsuo Murai; Kotaro Hirai; Kotaro Suzuki; Kiyoshi Fujinami; Teiichiro Ueki; Koichi Udagawa; Kazuo Kitami; Masatoshi Moriyama; Yasuhide Miyoshi; Futoshi Tsuchiya; Ichiro Ikeda; Kazuki Kobayashi; Maho Sato; Satoshi Morita; Kazumi Noguchi; Hiroji Uemura
Journal:  Oncotarget       Date:  2014-12-30

7.  Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case-control study.

Authors:  Naomi Boxall; Dimitri Bennett; Matthias Hunger; Paul Dolin; Paula L Thompson
Journal:  BMJ Open Diabetes Res Care       Date:  2016-12-12

8.  Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.

Authors:  Whi-An Kwon; Jae Young Joung; Jiwon Lim; Chang-Mo Oh; Kyu-Won Jung; Sung Han Kim; Ho Kyung Seo; Weon Seo Park; Jinsoo Chung; Kang Hyun Lee; Young-Joo Won
Journal:  BMC Cancer       Date:  2018-05-31       Impact factor: 4.430

9.  The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.

Authors:  Yuan Zhou; Han Guan; Yong Fu; Likai Mao; Jiyue Ge; Lutan Liu; Lei Cheng; Chao Guan
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

10.  Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression.

Authors:  Sayani Mukherjee; C Sudandiradoss
Journal:  Funct Integr Genomics       Date:  2021-06-29       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.